Could Vaxart Be a Warren Buffett Stock?
Science stocks aren't exactly Warren Buffett's usual fare for investment. Aside from the high risks involved with trying to make new medicines and technologies, many companies that work at the cutting edge of human knowledge haven't proven their value by generating revenue. So, it shouldn't surprise anyone that Buffett doesn't have any biotechnology companies in his portfolio.
Nonetheless, the small-cap vaccine maker Vaxart (NASDAQ: VXRT) might eventually have what it takes to win a spot in the Berkshire Hathaway stock roster. As outlandish as it might sound -- and it's definitely a long shot -- there's a path for the company to reach Buffett-stock status.
Image source: Getty Images
Source Fool.com
